Literature DB >> 16059452

AAN/AES guidelines on use of new AEDS.

Elinor Ben-Menachem.   

Abstract

Year:  2005        PMID: 16059452      PMCID: PMC1176324          DOI: 10.1111/j.1535-7597.2005.05108.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  4 in total

Review 1.  New antiepileptic drugs: comparison of key clinical trials.

Authors:  J A Cramer; R Fisher; E Ben-Menachem; J French; R H Mattson
Journal:  Epilepsia       Date:  1999-05       Impact factor: 5.864

Review 2.  Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation.

Authors:  J A Cramer; E Ben Menachem; J French
Journal:  Epilepsy Res       Date:  2001-11       Impact factor: 3.045

Review 3.  Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  J A French; A M Kanner; J Bautista; B Abou-Khalil; T Browne; C L Harden; W H Theodore; C Bazil; J Stern; S C Schachter; D Bergen; D Hirtz; G D Montouris; M Nespeca; B Gidal; W J Marks; W R Turk; J H Fischer; B Bourgeois; A Wilner; R E Faught; R C Sachdeo; A Beydoun; T A Glauser
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

Review 4.  Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  J A French; A M Kanner; J Bautista; B Abou-Khalil; T Browne; C L Harden; W H Theodore; C Bazil; J Stern; S C Schachter; D Bergen; D Hirtz; G D Montouris; M Nespeca; B Gidal; W J Marks; W R Turk; J H Fischer; B Bourgeois; A Wilner; R E Faught; R C Sachdeo; A Beydoun; T A Glauser
Journal:  Neurology       Date:  2004-04-27       Impact factor: 9.910

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.